Eli Lilly sponsored SURMOUNT-5, (NCT05822830), a Phase IIIb, open label, multi-centre, randomised clinical trial to compare the efficacy and safety of tirzepatide (Zepbound) versus semaglutide (Wegovy) in overweight or obese adults and at least one additional named weight-related comorbidity that was not T2D 24
Instead, its now thought that the polyphenolic compounds found in spinach are responsible
Compounded drugs have not been reviewed by the FDA for safety, efficacy, or manufacturing quality
[DOI] [PubMed] [Google Scholar] [84].Adam SS, Key NS, Greenberg CS
These patches are marketed as a convenient, needle-free alternative to GLP-1 injections, which sounds appealing if youre anxious about needles
They're derived from research investigating growth hormone secretagogue potency curves and receptor saturation thresholds